Register entry
Emergent BioSolutions Inc.
- Registered sites
- 3
- Drug products
- 3
- Live patents
- 0
- Countries
- 2
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackaging
Sites
Facilities
3| Site | Location | Operations | FEI |
|---|---|---|---|
| Emergent BioSolutions Canada Inc | WinnipegCanada | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3003153579 |
| Emergent Biodefense Operations Lansing LLC | Canton, MAUnited States | Analytical testing, Finished drug manufacture | 3004051669 |
| Emergent Biodefense Operations Lansing LLC | Lansing, MIUnited States | Analytical testing, Labelling, Finished drug manufacture, Packaging | 1873886 |
Catalogue
Marketed products
3Showing 3 of 3.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Anthrasil | Anthrax immune globulin (human) | LIQUID | BLA |
| BAT | Botulism Antitoxin Heptavalent | LIQUID | BLA |
| CNJ-016 | Vaccinia Immune Globulin Intravenous (Human) | INJECTION | BLA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.